Breaking News, Collaborations & Alliances

CMIC CMO, Rutgers Partner to Advance Pharmaceutical Manufacturing Excellence

Aims to integrate state-of-the-art infrastructure for rapid product and continuous process development in both non-GMP and GMP environments.

CMIC CMO USA and Rutgers partnered to establish a Center of Excellence in Advanced Pharmaceutical Manufacturing, co-located at CMIC’s 224,000 square foot facility in New Jersey.

Since 2006, the Rutgers School of Engineering has been at the forefront of pharmaceutical research through the Center for Structured Organic Particulate Systems (C-SOPS). C-SOPS has assembled a cross-disciplinary team of researchers from major universities, working in close collaboration with industry leaders and regulatory authorities to improve pharmaceutical, food, and agricultural product manufacturing methods.

Takahiro Ueda, CEO of CMIC CMO USA Corp., said, “Rutgers brings expertise in advanced and continuous manufacturing, while our suppliers provide the latest technological advances in equipment. This expertise allows us to integrate state-of-the-art infrastructure for rapid product and continuous process development in both non-GMP and GMP environments, giving CMIC unique capabilities to accelerate manufacturing of investigational and commercial products for the benefit of patients around the world.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters